To sum up, the bioinformatics strategy used in the current study revealed important roles of DKC1, PA2G4, NOLC1, LYAR, and E2F1 in the CRC carcinogenesis and potentiates these genes as biomarkers for detection of CRC and therapeutic targets for this cancer. This evidence concerns the gene LYAR and cancer.